Annual ROE
-46.49%
+63.83%+57.86%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual return on equity is -46.49%, with the most recent change of +63.83% (+57.86%) on December 1, 2023.
- During the last 3 years, XRTX annual ROE has risen by +55.76% (+54.53%).
- XRTX annual ROE is now -115.63% below its all-time high of 297.35%, reached on December 1, 2019.
Performance
XRTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-24.61%
+12.64%+33.93%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly return on equity is -24.61%, with the most recent change of +12.64% (+33.93%) on September 1, 2024.
- Over the past year, XRTX quarterly ROE has increased by +7.14% (+22.49%).
- XRTX quarterly ROE is now -100.38% below its all-time high of 6548.39%, reached on November 1, 2017.
Performance
XRTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
XRTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +57.9% | +22.5% |
| 3 y3 years | +54.5% | +70.0% |
| 5 y5 years | +96.0% | +70.0% |
XRTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -288.7% | +57.9% | -248.8% | +75.6% |
| 5 y | 5-year | -115.6% | +57.9% | -101.6% | +97.8% |
| alltime | all time | -115.6% | +96.0% | -100.4% | +99.9% |
XORTX Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -24.61%(-33.9%) |
| Jun 2024 | - | -37.25%(-42.6%) |
| Mar 2024 | - | -64.90%(+104.4%) |
| Dec 2023 | -46.49%(-57.9%) | -31.75%(-68.5%) |
| Sep 2023 | - | -100.70%(+7.9%) |
| Jun 2023 | - | -93.35%(+13.8%) |
| Mar 2023 | - | -82.03%(-6.8%) |
| Dec 2022 | -110.32%(+822.4%) | -88.06%(-632.4%) |
| Sep 2022 | - | 16.54%(-134.2%) |
| Jun 2022 | - | -48.43%(+9.1%) |
| Mar 2022 | - | -44.38%(+6.0%) |
| Dec 2021 | -11.96%(-88.3%) | - |
| Dec 2021 | - | -41.86%(-96.3%) |
| Sep 2021 | - | -1143.76%(+742.1%) |
| Jun 2021 | - | -135.83%(-18.8%) |
| Mar 2021 | - | -167.35%(+119.3%) |
| Dec 2020 | -102.25%(-134.4%) | -76.30%(+2.3%) |
| Sep 2020 | - | -74.59%(-5.3%) |
| Jun 2020 | - | -78.79%(-33.4%) |
| Mar 2020 | - | -118.39%(-107.6%) |
| Dec 2019 | 297.35% | 1554.06%(-658.4%) |
| Sep 2019 | - | -278.33%(+47.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | -188.95%(+39.2%) |
| Mar 2019 | - | -135.72%(-76.3%) |
| Dec 2018 | -1174.21%(-1720.9%) | -572.76%(-54.3%) |
| Sep 2018 | - | -1253.95%(-60.2%) |
| Jun 2018 | - | -3150.65%(-84.0%) |
| Mar 2018 | - | -19.67 K%(-2918.7%) |
| Dec 2017 | 72.44%(-130.3%) | 698.00%(-89.3%) |
| Nov 2017 | - | 6548.39%(-860.4%) |
| Sep 2017 | - | -861.19%(+239.8%) |
| Aug 2017 | - | -253.42%(+17.5%) |
| May 2017 | - | -215.64%(+11.2%) |
| Mar 2017 | - | -193.99%(+15.3%) |
| Feb 2017 | -239.21%(-282.9%) | -168.20%(+235.5%) |
| Dec 2016 | 130.82%(-270.9%) | - |
| Nov 2016 | - | -50.13%(-36.1%) |
| Aug 2016 | - | -78.49%(-8.9%) |
| May 2016 | - | -86.13%(-22.6%) |
| Feb 2016 | -76.53%(+148.8%) | -111.29%(-29.4%) |
| Nov 2015 | - | -157.74%(+14.3%) |
| Aug 2015 | - | -137.96%(+67.3%) |
| May 2015 | - | -82.48%(+162.8%) |
| Feb 2015 | -30.76% | -31.39% |
FAQ
- What is XORTX Therapeutics annual return on equity?
- What is the all time high annual ROE for XORTX Therapeutics?
- What is XORTX Therapeutics annual ROE year-on-year change?
- What is XORTX Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly ROE year-on-year change?
What is XORTX Therapeutics annual return on equity?
The current annual ROE of XRTX is -46.49%
What is the all time high annual ROE for XORTX Therapeutics?
XORTX Therapeutics all-time high annual return on equity is 297.35%
What is XORTX Therapeutics annual ROE year-on-year change?
Over the past year, XRTX annual return on equity has changed by +63.83% (+57.86%)
What is XORTX Therapeutics quarterly return on equity?
The current quarterly ROE of XRTX is -24.61%
What is the all time high quarterly ROE for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly return on equity is 6548.39%
What is XORTX Therapeutics quarterly ROE year-on-year change?
Over the past year, XRTX quarterly return on equity has changed by +7.14% (+22.49%)